A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease

NCT05280548 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Fabry Disease

Interventions

DRUG: Venglustat (GZ402671)
DRUG: Agalsidase alfa
DRUG: Agalsidase beta (GZ419828)
DRUG: Migalastat

Sponsor

Sanofi